Emmaus Life Sciences (EMMA) Form 4 Emmaus Life Sciences / Yutaka Niihara ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Niihara Yutaka

(Last) (First) (Middle)

21250 HAWTHORNE BLVD.

SUITE 800

(Street)

TORRANCE CA 90503

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Emmaus Life Sciences, Inc. [ EMMA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.001 par value	08/29/2019		P		600	A	$3.06	11,101	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		100	A	$3.09	11,201	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		500	A	$3.11	11,701	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		200	A	$3.12	11,901	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		200	A	$3.13	12,101	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		1,400	A	$3.135	13,501	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		600	A	$3.145	14,101	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		1,300	A	$3.15	15,401	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		300	A	$3.155	15,701	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		300	A	$3.16	16,001	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		800	A	$3.165	16,801	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		2,500	A	$3.17	19,301	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		2,000	A	$3.175	21,301	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		900	A	$3.18	22,201	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		100	A	$3.19	22,301	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		400	A	$3.2	22,701	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		500	A	$3.21	23,201	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		470	A	$3.22	23,671	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		200	A	$3.23	23,871	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		1,100	A	$3.24	24,971	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		3,100	A	$3.25	28,071	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		600	A	$3.26	28,671	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		1,630	A	$3.27	30,301	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		100	A	$3.28	30,401	I	By Soomi Niihara
Common stock, $0.001 par value	08/29/2019		P		100	A	$3.3	30,501	I	By Soomi Niihara
Common stock, $0.001 par value								10,221,626	D(1)
Common stock, $0.001 par value								92,794	I	By Hope International Hospice, Inc.(2)
Common stock, $0.001 par value								46,446	I	As custodian(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares shown and all other shares shown in this Report as owned directly include shares owned jointly with Soomi Niihara, the reporting person's wife.

2. Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.

3. The shares shown are held by Dr. Niihara as custodian for the benefit of his adult children. Dr. Niihara disclaims beneficial ownership of such shares. The inclusion in this Report of such shares shall not be deemed an admission that Dr. Niihara is the beneficial owners of such shares for purposes of Section 16 or for any other purpose.

Remarks:

	Yutaka Niihara, M.D., M.P.H.	08/30/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.